US Hospital Stays in Children and Adolescents With Acetaminophen Poisoning

Kristin A Shadman1, M Bruce Edmonson1, Ryan J Coller1

  • 1Departments of Pediatrics.

Hospital Pediatrics
|January 20, 2022
PubMed

Insights

Acetaminophen poisoning led to over 9,900 hospitalizations in U.S. children in 2016. This common poisoning in adolescents highlights the need for enhanced prevention strategies to reduce hospital stays.

Area of Science:

  • Pediatrics
  • Toxicology
  • Public Health

Background:

  • Acetaminophen poisoning is a significant health concern across all age groups.
  • Hospital-based outcomes for pediatric acetaminophen poisoning require further characterization.
  • Understanding intentionality is crucial for effective intervention.

Purpose of the Study:

  • To determine the incidence and characteristics of hospital stays for acetaminophen poisoning in children.
  • To analyze the outcomes of pediatric acetaminophen poisoning hospitalizations.
  • To evaluate the role of intentionality in these poisonings.

Main Methods:

  • Utilized the 2016 Kids' Inpatient Database for hospitalization data.
  • Employed validated International Classification of Diseases, 10th Revision (ICD-10) codes.
  • Applied standard survey methods for weighted population estimates and outcome analysis, stratified by intentionality.

Main Results:

  • In 2016, there were 9,935 hospitalizations for acetaminophen poisoning in U.S. children (0-19 years).
  • Acetaminophen was the most frequent agent in self-harm medication poisonings among children.
  • Nearly half of discharges were transferred to other facilities, indicating complex care needs.

Conclusions:

  • Acetaminophen poisoning represents a leading cause of U.S. pediatric hospitalizations for medication self-harm.
  • There is a critical need for improved prevention strategies targeting acetaminophen poisoning in adolescents.
  • Reducing the incidence of this common malady requires focused public health interventions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
12
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
21
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
953